Skip to main content
Clinical Trials/IRCT201010022622N2
IRCT201010022622N2
Completed
Phase 2

Comparing the effect of continuous infusion of low dose Methyl Prednisolone with its single dose on reducing the inflammatory mediators and improvement of renal function in patients who undergo open heart surgery

Tehran Heart Center0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
coronary artery disease.
Sponsor
Tehran Heart Center
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tehran Heart Center

Eligibility Criteria

Inclusion Criteria

  • 1\- age over 18\. 2\- written informed consent. 3\- patients who are candidate for open heart surgery.
  • Exclusion criteria: 1\- recent use of systemic corticosteroid. 2\- history of bacterial or fungal infection in the past two weeks. 3\- history of sensitivity to corticosteroids. 4\- uncontrolled diabetes mellitus. 5\- history of renal failure 6\- liver failure or elevated liver enzymes.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials